{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:53:53Z","timestamp":1791971633730,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001862"],"award-info":[{"award-number":["KL2TR001862"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001863"],"award-info":[{"award-number":["UL1TR001863"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001455","name":"American Foundation for Suicide Prevention","doi-asserted-by":"publisher","award":["YIG-0-033-21"],"award-info":[{"award-number":["YIG-0-033-21"]}],"id":[{"id":"10.13039\/100001455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD026810"],"award-info":[{"award-number":["S10OD026810"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA 22975-15"],"award-info":[{"award-number":["T32 DA 22975-15"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K08MH141526"],"award-info":[{"award-number":["K08MH141526"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["5R01MH131720-03"],"award-info":[{"award-number":["5R01MH131720-03"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["5R21MH122887-02"],"award-info":[{"award-number":["5R21MH122887-02"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biopsych.2026.06.017","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:02:07Z","timestamp":1782774127000},"page":"1045-1054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kappa Opioid Receptor Availability in Borderline Personality Disorder: An In Vivo Investigation With [11C]EKAP Positron Emission Tomography Imaging"],"prefix":"10.1016","volume":"100","author":[{"given":"Emily R.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Naganawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth H.","family":"Asch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Hart-Derrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayna","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Jean","family":"Duraney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Nabulsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Matuskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Enferadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret T.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2026.06.017_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/wps.21156","article-title":"Borderline personality disorder: A comprehensive review of diagnosis and clinical presentation, etiology, treatment, and current controversies","volume":"23","author":"Leichsenring","year":"2024","journal-title":"World Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4088\/JCP.v69n0404","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions","volume":"69","author":"Grant","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11920-012-0335-2","article-title":"Components of emotion dysregulation in borderline personality disorder: A review","volume":"15","author":"Carpenter","year":"2013","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.biopsych.2026.06.017_bib4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.31887\/DCNS.2013.15.2\/lripoll","article-title":"Psychopharmacologic treatment of borderline personality disorder","volume":"15","author":"Ripoll","year":"2013","journal-title":"Dial Clin Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.017_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4088\/JCP.08r04526gre","article-title":"Effectiveness of pharmacotherapy for severe personality disorders: Meta-analyses of randomized controlled trials","volume":"71","author":"Ingenhoven","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: Distinct roles in mood disorders","volume":"36","author":"Lutz","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.017_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pnpbp.2015.01.001","article-title":"Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment","volume":"62","author":"Crowley","year":"2015","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neubiorev.2015.01.001","article-title":"Emotional sensitivity, emotion regulation and impulsivity in borderline personality disorder: A critical review of fMRI studies","volume":"51","author":"van Zutphen","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2026.06.017_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/npp.2013.236","article-title":"Pain-related depression of the mesolimbic dopamine system in rats: Expression, blockade by analgesics, and role of endogenous \u03ba-opioids","volume":"39","author":"Leitl","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.017_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1176\/appi.ajp.2010.10040634","article-title":"An opioid deficit in borderline personality disorder: self-cutting, substance abuse, and social dysfunction","volume":"167","author":"New","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1037\/a0022695","article-title":"Mu-opioid receptor (OPRM1) variation, oxytocin levels and maternal attachment in free-ranging rhesus macaques Macaca mulatta","volume":"125","author":"Higham","year":"2011","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.017_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jad.2009.10.028","article-title":"Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters","volume":"124","author":"Stanley","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.biopsych.2026.06.017_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1037\/a0018095","article-title":"Borderline personality disorder: A dysregulation of the endogenous opioid system?","volume":"117","author":"Bandelow","year":"2010","journal-title":"Psychol Rev"},{"key":"10.1016\/j.biopsych.2026.06.017_bib14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1176\/appi.ajp.2018.18020138","article-title":"Attenuation of antidepressant effects of ketamine by opioid receptor antagonism","volume":"175","author":"Williams","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpsychires.2014.07.027","article-title":"Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety","volume":"58","author":"Ballard","year":"2014","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2026.06.017_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2005.12.002","article-title":"Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects","volume":"531","author":"Jutkiewicz","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.017_bib17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/da.22500","article-title":"Kappa-opioid antagonists for psychiatric disorders: From bench to clinical trials","volume":"33","author":"Carlezon","year":"2016","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2026.06.017_bib18","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00213-020-05473-4","article-title":"Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys","volume":"237","author":"Zamarripa","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.017_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin \u03ba-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.017_bib20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00213-009-1771-5","article-title":"The discriminative effects of the \u03ba-opioid hallucinogen salvinorin A in nonhuman primates: Dissociation from classic hallucinogen effects","volume":"210","author":"Butelman","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.017_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, stress, and depression","volume":"1314","author":"Knoll","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2026.06.017_bib22","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1038\/tp.2013.72","article-title":"Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment","volume":"3","author":"Kuzmin","year":"2013","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib23","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1523\/JNEUROSCI.2980-11.2012","article-title":"Stress-induced activation of the dynorphin\/\u03ba-opioid receptor system in the amygdala potentiates nicotine conditioned place preference","volume":"32","author":"Smith","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.017_bib24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2026.06.017_bib25","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1523\/JNEUROSCI.5779-11.2012","article-title":"\u03ba-Opioid receptors within the nucleus accumbens shell mediate pair bond maintenance","volume":"32","author":"Resendez","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.017_bib26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","article-title":"Role of kappa-opioid receptors in stress and anxiety-related behavior","volume":"229","author":"Van\u2019t Veer","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.017_bib27","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00005053-200208000-00003","article-title":"Traumatic exposure and posttraumatic stress disorder in borderline, schizotypal, avoidant, and obsessive-compulsive personality disorders: Findings from the collaborative longitudinal personality disorders study","volume":"190","author":"Yen","year":"2002","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2026.06.017_bib28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuron.2019.02.029","article-title":"Pain-induced negative affect is mediated via recruitment of the nucleus accumbens kappa opioid system","volume":"102","author":"Massaly","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2026.06.017_bib29","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/s41386-019-0379-7","article-title":"Social status and demographic effects of the kappa opioid receptor: A PET imaging study with a novel agonist radiotracer in healthy volunteers","volume":"44","author":"Matuskey","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.017_bib30","series-title":"Structured Clinical Interview for DSM-5 Disorders, Clinician Version","author":"First","year":"2015"},{"key":"10.1016\/j.biopsych.2026.06.017_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1521\/pedi.17.6.568.25355","article-title":"A screening measure for BPD: The McLean screening instrument for borderline personality disorder (MSI-BPD)","volume":"17","author":"Zanarini","year":"2003","journal-title":"J Pers Disord"},{"key":"10.1016\/j.biopsych.2026.06.017_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1037\/pas0000486","article-title":"The Clinician-Administered PTSD Scale for DSM\u20135 (CAPS-5): Development and initial psychometric evaluation in military veterans","volume":"30","author":"Weathers","year":"2018","journal-title":"Psychol Assess"},{"key":"10.1016\/j.biopsych.2026.06.017_bib33","series-title":"Beck Depression Inventory-II (BDI-II)","author":"Beck","year":"1996"},{"key":"10.1016\/j.biopsych.2026.06.017_bib34","first-page":"145","article-title":"The State-Trait Anxiety Inventory","volume":"5","author":"Spielberger","year":"1971","journal-title":"Interamerican J Psychol"},{"key":"10.1016\/j.biopsych.2026.06.017_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000173701","article-title":"The short version of the Borderline Symptom List (BSL-23): Development and initial data on psychometric properties","volume":"42","author":"Bohus","year":"2009","journal-title":"Psychopathology"},{"key":"10.1016\/j.biopsych.2026.06.017_bib36","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.biopsych.2026.06.017_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0145-2134(02)00541-0","article-title":"Development and validation of a brief screening version of the Childhood Trauma Questionnaire","volume":"27","author":"Bernstein","year":"2003","journal-title":"Child Abuse Negl"},{"key":"10.1016\/j.biopsych.2026.06.017_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jts.22059","article-title":"The posttraumatic stress disorder checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation","volume":"28","author":"Blevins","year":"2015","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.biopsych.2026.06.017_bib39","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10862-016-9547-9","article-title":"Validation of a brief version of the difficulties in emotion regulation scale (DERS-18) in five samples","volume":"38","author":"Victor","year":"2016","journal-title":"J Psychopathol Behav Assess"},{"key":"10.1016\/j.biopsych.2026.06.017_bib40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2967\/jnumed.118.220517","article-title":"Development and in vivo evaluation of a \u03ba-opioid receptor agonist as a PET radiotracer with superior imaging characteristics","volume":"60","author":"Li","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2026.06.017_bib41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2026.06.017_bib42","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2026.06.017_bib43","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2967\/jnumed.119.227694","article-title":"Kinetic modeling and test-retest reproducibility of 11C-EKAP and 11C-FEKAP, novel agonist radiotracers for PET imaging of the \u03ba-opioid receptor in humans","volume":"61","author":"Naganawa","year":"2020","journal-title":"J Nucl Med"},{"issue":"Spec No","key":"10.1016\/j.biopsych.2026.06.017_bib44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/FBP.0000000000000155","article-title":"Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin\/kappa-opioid receptor system","volume":"26","author":"Donahue","year":"2015","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.017_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22042","article-title":"Kappa opioid receptor binding in major depression: A pilot study","volume":"72","author":"Miller","year":"2018","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2026.06.017_bib46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.biopsych.2017.07.012","article-title":"Epigenetic regulation of the kappa opioid receptor by child abuse","volume":"84","author":"Lutz","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib47","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/B978-0-12-823493-8.00015-8","article-title":"Amygdala function in emotion, cognition, and behavior","volume":"187","author":"Dom\u00ednguez-Borr\u00e0s","year":"2022","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.biopsych.2026.06.017_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.963691","article-title":"Dynorphin\/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders","volume":"16","author":"Limoges","year":"2022","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.017_bib49","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41398-021-01729-5","article-title":"Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography","volume":"11","author":"Smart","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib50","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41386-019-0398-4","article-title":"Kappa-opioid receptors, dynorphin, and cocaine addiction: A positron emission tomography study","volume":"44","author":"Martinez","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.017_bib51","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41386-024-01975-3","article-title":"Kappa Opioid receptor availability predicts severity of anhedonia in schizophrenia","volume":"49","author":"Slifstein","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.017_bib52","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/NDT.S367839","article-title":"Anhedonia in depression and schizophrenia: Brain reward and aversion circuits","volume":"18","author":"Liang","year":"2022","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.biopsych.2026.06.017_bib53","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12974-022-02643-3","article-title":"The dynorphin\/kappa opioid receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma","volume":"19","author":"Lee","year":"2022","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.biopsych.2026.06.017_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41398-020-00915-1","article-title":"Exploring the impact of trauma type and extent of exposure on posttraumatic alterations in 5-HT1A expression","volume":"10","author":"Lewis","year":"2020","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.017_bib55","first-page":"335","article-title":"Kappa opioid receptor availability in borderline personality disorder and suicidal behavior: Preliminary results from a [11C]EKAP PET study","volume":"47","author":"Davis","year":"2022","journal-title":"ACNP 61st Annual Meeting: Poster Abstract P471. Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.017_bib56","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.biopsych.2022.02.438","article-title":"P204. Role of kappa opioid receptor availability in borderline personality disorder and suicidal behavior: Preliminary results from an in vivo [11C]EKAP PET study","volume":"91","author":"Davis","year":"2022","journal-title":"Biol Psychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326013569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326013569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:30:30Z","timestamp":1791970230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322326013569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0006322326013569"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.06.017","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kappa Opioid Receptor Availability in Borderline Personality Disorder: An In Vivo Investigation With [11C]EKAP Positron Emission Tomography Imaging","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}